Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs LUPIN - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DISHMAN PHARMA LUPIN DISHMAN PHARMA/
LUPIN
 
P/E (TTM) x 30.0 415.8 7.2% View Chart
P/BV x 3.3 2.9 113.8% View Chart
Dividend Yield % 0.7 0.5 128.8%  

Financials

 DISHMAN PHARMA   LUPIN
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
LUPIN
Mar-22
DISHMAN PHARMA/
LUPIN
5-Yr Chart
Click to enlarge
High Rs3741,268 29.5%   
Low Rs129679 19.0%   
Sales per share (Unadj.) Rs197.0361.0 54.6%  
Earnings per share (Unadj.) Rs21.2-33.2 -63.8%  
Cash flow per share (Unadj.) Rs34.73.3 1,058.6%  
Dividends per share (Unadj.) Rs2.004.00 50.0%  
Avg Dividend yield %0.80.4 193.3%  
Book value per share (Unadj.) Rs179.9263.9 68.2%  
Shares outstanding (eoy) m80.70454.48 17.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.32.7 47.4%   
Avg P/E ratio x11.9-29.3 -40.5%  
P/CF ratio (eoy) x7.3296.8 2.4%  
Price / Book Value ratio x1.43.7 37.9%  
Dividend payout %9.4-12.0 -78.4%   
Avg Mkt Cap Rs m20,307442,238 4.6%   
No. of employees `000NANA-   
Total wages/salary Rs m5,35529,893 17.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m15,898164,055 9.7%  
Other income Rs m2652,137 12.4%   
Total revenues Rs m16,163166,192 9.7%   
Gross profit Rs m4,1032,152 190.6%  
Depreciation Rs m1,09116,587 6.6%   
Interest Rs m9441,428 66.1%   
Profit before tax Rs m2,334-13,726 -17.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6241,372 45.5%   
Profit after tax Rs m1,710-15,097 -11.3%  
Gross profit margin %25.81.3 1,967.2%  
Effective tax rate %26.7-10.0 -267.4%   
Net profit margin %10.8-9.2 -116.9%  
BALANCE SHEET DATA
Current assets Rs m11,018124,577 8.8%   
Current liabilities Rs m9,51782,764 11.5%   
Net working cap to sales %9.425.5 37.0%  
Current ratio x1.21.5 76.9%  
Inventory Days Days5733 172.2%  
Debtors Days Days395 3.7%  
Net fixed assets Rs m18,78791,938 20.4%   
Share capital Rs m161909 17.8%   
"Free" reserves Rs m14,354119,006 12.1%   
Net worth Rs m14,516119,915 12.1%   
Long term debt Rs m4,1891,419 295.3%   
Total assets Rs m29,805216,515 13.8%  
Interest coverage x3.5-8.6 -40.3%   
Debt to equity ratio x0.30 2,439.7%  
Sales to assets ratio x0.50.8 70.4%   
Return on assets %8.9-6.3 -141.1%  
Return on equity %11.8-12.6 -93.6%  
Return on capital %17.5-10.1 -172.9%  
Exports to sales %24.90-   
Imports to sales %3.70-   
Exports (fob) Rs m3,956NA-   
Imports (cif) Rs m594NA-   
Fx inflow Rs m4,95253,594 9.2%   
Fx outflow Rs m69738,143 1.8%   
Net fx Rs m4,25515,451 27.5%   
CASH FLOW
From Operations Rs m2,7863,673 75.9%  
From Investments Rs m-1,52912,922 -11.8%  
From Financial Activity Rs m-941-15,723 6.0%  
Net Cashflow Rs m317872 36.3%  

Share Holding

Indian Promoters % 61.4 46.8 131.1%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 23.0 43.4 52.9%  
FIIs % 12.0 14.0 85.6%  
ADR/GDR % 0.0 0.0 -  
Free float % 38.6 52.9 73.0%  
Shareholders   52,291 360,677 14.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DISHMAN PHARMA With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    AUROBINDO PHARMA    ZYDUS LIFESCIENCES    


More on Dishman Pharma vs Lupin

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Dishman Pharma vs Lupin Share Price Performance

Period Dishman Pharma Lupin S&P BSE HEALTHCARE
1-Day 2.87% 3.11% 1.20%
1-Month -2.45% 3.48% -3.18%
1-Year 96.38% -1.59% -7.59%
3-Year CAGR 89.34% 3.38% 16.43%
5-Year CAGR 38.20% -0.98% 9.40%

* Compound Annual Growth Rate

Here are more details on the Dishman Pharma share price and the Lupin share price.

Moving on to shareholding structures...

The promoters of Dishman Pharma hold a 61.4% stake in the company. In case of Lupin the stake stands at 47.1%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Dishman Pharma and the shareholding pattern of Lupin.

Finally, a word on dividends...

In the most recent financial year, Dishman Pharma paid a dividend of Rs 2.0 per share. This amounted to a Dividend Payout ratio of 9.4%.

Lupin paid Rs 4.0, and its dividend payout ratio stood at -12.0%.

You may visit here to review the dividend history of Dishman Pharma, and the dividend history of Lupin.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Ends 378 Points Higher | Nifty Ends Above 17,850 | Paytm & Adani Enterprises Rally 15% Sensex Today Ends 378 Points Higher | Nifty Ends Above 17,850 | Paytm & Adani Enterprises Rally 15%(Closing)

After opening the day on a positive note, Indian share markets continued their momentum as the session progressed and ended higher.